University of Florida College of Medicine welcomes new pediatric neurology chief
Previously an associate professor of neurology at Harvard Medical School, Kang was also the director of the electromyography laboratory at Boston Children’s Hospital, where he cared for children with neuromuscular diseases and performed electrophysiologic diagnostic studies. He also started a research laboratory, which he will expand at UF, focusing on the genetics of muscular dystrophy and other pediatric neuromuscular disorders. Kang serves as the principal investigator on grants from the National Institutes of Health and the Muscular Dystrophy Association.
“Good care is imperative for children with neurological disorders,” said Kang, “and there is a need to continue to grow our capabilities in this area. I’m encouraged by the outstanding academic environment that UF offers, along with its energetic and collaborative faculty, which will enable us to expand research and clinical activities within the division.”
Kang completed medical school at the University of Pennsylvania, pediatric residency at Yale-New Haven Hospital, a pediatric neurology residency at the University of Pennsylvania and a fellowship in clinical neurophysiology at Beth Israel Deaconess Medical Center.
“We are delighted to have Dr. Kang, who is an internationally recognized expert in neuromuscular diseases, lead our pediatric neurology program,” said Scott Rivkees, M.D., chair of the UF College of Medicine department of pediatrics. “He brings his exceptional expertise in the care of children and a top research program that will lead to tomorrow’s cures. Our pediatric neurology program is already recognized as one of the top programs in the United States. Under Dr. Kang’s leadership we’re confident that it will rise to even greater heights.”
The mission of the division of pediatric neurology is to achieve national prominence in education, research and patient care by developing multidisciplinary programs in epilepsy, sleep disorders, neuromuscular disorders, movement disorders, autism, neuro-oncology and cognitive neurology.